<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Pharmaceutical, medical &amp; healthcare market Central and Eastern Europe</title>
    <description>Latest and most important pharmaceutical, medical and health care market news. Free articles, market commentaries, newsletters and detailed market reports.</description>
    <link>http://www.ceepharma.com/</link>
    <lastBuildDate>Fri, 18 May 2012 03:30:30 +0200</lastBuildDate>
    <image>
      <url>http://www.polishmarket.com/_i/images/PMR.gif</url>
      <title></title>
      <link>http://www.ceepharma.com/</link>
      <width>100</width>
      <height>51</height>
      <description>Latest and most important pharmaceutical, medical and health care market news. Free articles, market commentaries, newsletters and detailed market reports.</description>
    </image>
    <item>
      <title>Gedeon Richter’s sales revenues in Slovakia up to €5.9m in Q1 2012</title>
      <link>http://www.ceepharma.com/121728/Gedeon_Richter__8217_s_sales_revenues_in_Slovakia_up_to___8364_5_9m_in_Q1_2012.shtml</link>
      <description> In the first quarter of 2012, the sales of Gedeon Richter, the prominent Hungarian drug manufacturer, in Slovakia were worth €5.9m, a €2m increase in comparison with&lt;/I&gt; ... </description>
      <pubDate>Fri, 11 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Hungaropharma closes trade centre in Bekescsaba</title>
      <link>http://www.ceepharma.com/121677/Hungaropharma_closes_trade_centre_in_Bekescsaba.shtml</link>
      <description> Hungaropharma, one of the largest pharmaceutical wholesalers in Hungary, has announced that it intends to close its trade centre in Bekescsaba because of the effects of the Kalman&lt;/I&gt; ... </description>
      <pubDate>Thu, 10 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>GSK Romania launches partnership with Desitin to promote new medicine</title>
      <link>http://www.ceepharma.com/121676/GSK_Romania_launches_partnership_with_Desitin_to_promote_new_medicine.shtml</link>
      <description> The Romanian subsidiary of GlaxoSmithKline (GSK) and Desitin Pharma, the local subsidiary of the German pharmaceutical company Desitin Arzneimittel, have signed a collaboration agreement pertaining&lt;/I&gt; ... </description>
      <pubDate>Thu, 10 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Arx Equity Partners to complete PE investment in Polish healthcare sector in 2012</title>
      <link>http://www.ceepharma.com/150127/Arx_Equity_Partners_to_complete_PE_investment_in_Polish_healthcare_sector_in_2012.shtml</link>
      <description> Arx Equity Partners, which owns Lexummedica, a network of ophthalmic clinics in Poland and the Czech Republic, has not managed to complete a private equity (PE) investment in the&lt;/I&gt; ... </description>
      <pubDate>Wed, 09 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Foreign patients owe Czech hospital CZK 36m for treatment</title>
      <link>http://www.ceepharma.com/121599/Foreign_patients_owe_Czech_hospital_CZK_36m_for_treatment.shtml</link>
      <description> In 2011, Czech hospitals provided medical care to 83,849 foreigners for the amount of CZK 634m (€25.1m), according to the Institute of Health Information and Statistics of&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sopharma’s net profit down by 19.5% in Q1 2012</title>
      <link>http://www.ceepharma.com/121586/Sopharma__8217_s_net_profit_down_by_19_5__in_Q1_2012.shtml</link>
      <description> Sopharma, the prominent Bulgarian drug manufacturer, recorded a 19.5% year on year reduction in its consolidated net profit to BGN 8.44m (€4.3m) in the first quarter of 2012.&#13;
At&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Kalman Szell Plan 2.0. envisages further changes in Hungarian reimbursement system</title>
      <link>http://www.ceepharma.com/121297/Kalman_Szell_Plan_2_0__envisages_further_changes_in_Hungarian_reimbursement_system.shtml</link>
      <description> The second version of the Kalman Szell Plan structural reform programme for 2013, announced by the Hungarian government on 23 April 2012, envisages the introduction of the “Spanish-model”&lt;/I&gt; ... </description>
      <pubDate>Tue, 01 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Bulgaria to amend drug discount negotiation procedures</title>
      <link>http://www.ceepharma.com/121215/Bulgaria_to_amend_drug_discount_negotiation_procedures.shtml</link>
      <description> On 25 April, Bulgaria’s health ministry started a two-week public consultation on the draft amendments to Regulation No. 10, which pertains to the procedure for the reimbursement&lt;/I&gt; ... </description>
      <pubDate>Mon, 30 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>New reimbursement list announced in Poland</title>
      <link>http://www.ceepharma.com/121088/New_reimbursement_list_announced_in_Poland.shtml</link>
      <description> The Health Ministry on 25 April published an official announcement about changes to the list of reimbursed medicines due to take effect on 1 May.&#13;
The updated list includes 3,137&lt;/I&gt; ... </description>
      <pubDate>Thu, 26 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Stada reports 20% sales growth in 2011 in Slovakia</title>
      <link>http://www.ceepharma.com/121053/Stada_reports_20__sales_growth_in_2011_in_Slovakia.shtml</link>
      <description> In 2011 sales generated in Slovakia by Stada Arzneimittel amounted to €8.5m, which stands for a 20% increase in comparison to the corresponding period of the previous year.&lt;/I&gt; ... </description>
      <pubDate>Wed, 25 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Ranbaxy to launch Daiichi Sankyo's antihypertensive in Romania</title>
      <link>http://www.ceepharma.com/121021/Ranbaxy_to_launch_Daiichi_Sankyo_s_antihypertensive_in_Romania.shtml</link>
      <description> Terapia Ranbaxy, one of the largest drug manufacturers in Romania, will launch Japan’s Daiichi Sankyo's Sevikar tablets for the treatment of essential hypertension in Romania.&lt;/I&gt; ... </description>
      <pubDate>Tue, 24 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Czech Republic reintroduces reimbursed drugs bonuses</title>
      <link>http://www.ceepharma.com/120918/Czech_Republic_reintroduces_reimbursed_drugs_bonuses.shtml</link>
      <description> As of 1 April 2012, Czech pharmacies are allowed to offer bonuses, gifts and other non-monetary benefits to patients acquiring reimbursed prescription medicines. This possibility&lt;/I&gt; ... </description>
      <pubDate>Mon, 23 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Anzag acquires another 20% stake in Farmexpert</title>
      <link>http://www.ceepharma.com/120724/Anzag_acquires_another_20__stake_in_Farmexpert.shtml</link>
      <description> Anzag, a German pharmaceutical wholesaler, bought an additional 20% stake in the Romanian medicine distributor Farmexpert. Following this transaction, ANZAG reached a total stake of&lt;/I&gt; ... </description>
      <pubDate>Tue, 17 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Reduction in cost of 180 cancer drugs proposed in Bulgaria</title>
      <link>http://www.ceepharma.com/120663/Reduction_in_cost_of_180_cancer_drugs_proposed_in_Bulgaria.shtml</link>
      <description> The Bulgarian National Health Insurance Fund (NHIF) has said that 43 companies have proposed reductions in the prices of 180 drugs used for hospital cancer treatment. The discounts&lt;/I&gt; ... </description>
      <pubDate>Tue, 17 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Batch of Fortimax withdrawn from the Hungarian market</title>
      <link>http://www.ceepharma.com/120659/Batch_of_Fortimax_withdrawn_from_the_Hungarian_market.shtml</link>
      <description> On 29 March 2012, the National Institute of Pharmacy (OGYI) of the Institute for the Improvement of Quality and Organisation in the Pharmaceutical Industry and in Healthcare (GYEMSZI)&lt;/I&gt; ... </description>
      <pubDate>Tue, 17 Apr 2012 00:00:00 +0200</pubDate>
    </item>
  </channel>
</rss>
<!--

		There was 4 queries

		
			CONNECT TO admin402@mysqls.polishmarket.serwery.pl;
			time: not available
			
			SET NAMES latin2;
			time: 0.00015401840209961
			
			USE baza402;
			time: not available
			
			SELECT id,	news_feature, title, content, date FROM arch_item WHERE news_feature = 1 AND dostepny = 1 AND new_category IN (136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 219, 220, 221, 222, 265, 266, 267, 268) ORDER BY date DESC, id DESC LIMIT 15;
			time: 0.00093889236450195
			

		Total script time: 0.008781909942627-->

<!-- float(0.008821964263916)
 -->
